Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 29, 1997 - Issue 1
Submit an article Journal homepage
36
Views
36
CrossRef citations to date
0
Altmetric
Original Article

Genotype, Viral Load and Age as Independent Predictors of Treatment Outcome of Interferon-α2a Treatment in Patients with Chronic Hepatitis C

Helge Bell Unit of Hepatology, Department of Medicine, Department of Pathology, Aker University Hospital, Oslo
,
Kjell Hellum Department of Medicine, Central Hospital of Akershus, Bergen
,
Stig Harthug Department of Medicine, Haukeland University Hospital, Bergen
,
Arild Mæland Department of Medicine, University Hospital of Ullevål, Oslo
,
Ståle Ritland Department of Medicine, Central Hospital of Buskerud, Drammen
,
Bjørn Myrvang Department of Medicine, University Hospital of Ullevål, Oslo
,
Bent Von Der Lippe Department of Medicine, University Hospital of Ullevål, Oslo
,
Nils Raknerud Unit of Hepatology, Department of Medicine, Department of Pathology, Aker University Hospital, Oslo
,
Kjell Skaug Department of Virology, National Institute of Health, Oslo
,
Bjørg-Guri Gutigard Department of Virology, National Institute of Health, Oslo
,
Rolv Skjærven Section for Medical Informatics and Statistics, University of Bergen, Norway
,
Linda E. Prescott Department of Medical Microbiology, University of Edinburgh, UK
&
Peter Simmonds Department of Medical Microbiology, University of Edinburgh, UK
 show all
Pages 17-22 | Received 06 May 1996, Accepted 31 Oct 1996, Published online: 08 Jul 2009

Citations (36)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

L. M. JARVIS, H. BELL, P. SIMMONDS, A. HAWKINS, K. HELLUM, S. HARTHUG, A. MÆLAND, S. RITLAND, B. MYRVANG, B. VON DER LIPPE, N. RAKNERUD, K. SKAUG, P. SIMMONDS. (1998) The Effect of Treatment with a-Interferon on Hepatitis G/GBV-C Viraemia. Scandinavian Journal of Gastroenterology 33:2, pages 195-200.
Read now

Articles from other publishers (35)

Md Arifur Rahman, Md Monirul Islam, Md Eunus Ali, Mohammad Ariful Islam, Farhana Afroze, Mohammad Shamim Hossain & Ahmed Abu Rus'd. (2023) Molecular Epidemiology of HCV RNA Genotype-3 in Dhaka City, Bangladesh. Global Medical Genetics 10:03, pages 199-204.
Crossref
Farah Bokharaei-Salim, Mostafa Salehi-Vaziri, Farzin Sadeghi, Maryam Esghaei, Seyed Hamidreza Monavari, Seyed Moayed Alavian, Shahin Fakhim & Hossein Keyvani. (2016) The Association of Substitutions in the Hepatitis C Virus Subtype 1b Core Gene and IL28B Polymorphisms With the Response to Peg-IFNα-2a/RBV Combination Therapy in Azerbaijani Patients. Hepatitis Monthly 16:5.
Crossref
Sobia Kanwal & Tariq Mahmood. (2014) Occurrence of genetic modifications in core, 5′UTR and NS5b of HCV associated with viral response to treatment. Virology Journal 11:1.
Crossref
Farzin Sadeghi, Farah Bokharaei-Salim, Mostafa Salehi-Vaziri, Seyed Hamidreza Monavari, Seyed Moayed Alavian, Shima Salimi, Rouhollah Vahabpour & Hossein Keyvani. (2014) Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNα-2a and ribavirin in Iranian patients with chronic hepatitis C. Journal of Medical Virology 86:9, pages 1499-1506.
Crossref
Arnolfo Petruzziello, Nicola Coppola, Giovanna Loquercio, Samantha Marigliano, Margherita Giordano, Rosa Azzaro, Anna Maria Diodato, Vincenzo Iervolino, Gaetano Di Costanzo, Catia Addolorata Di Macchia, Tommaso Di Meo, Laurenza Paradiso, Rosario Ferro, Pasquale Giuliano, Ferdinando Russo, Giuseppe Pasquale & Carmela Cacciapuoti. (2014) Distribution Pattern of Hepatitis C Virus Genotypes and Correlation with Viral Load and Risk Factors in Chronic Positive Patients. Intervirology 57:6, pages 311-318.
Crossref
Asim Mushtaq, Mujahid Azeem Tariq, Umer Rashid, Amber Afroz, Nadia Zeeshan, Abdul R. Asif & Muzna Zahur. (2013) Estimation of HCV viral load and liver enzymes among different patients groups of District Gujrat, Pakistan. Advances in Bioscience and Biotechnology 04:09, pages 866-871.
Crossref
Amjad Ali, Muhammad Nisar, Habib Ahmad, Nausheen Saif, Muhammad Idrees & Mohammad A Bajwa. (2011) Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan. Virology Journal 8:1.
Crossref
Yong-Hak Sohn, Sun-Young Ko, Myeong Hee Kim & Heung-Bum Oh. (2010) Performance evaluation of the Abbott RealTime HCV Genotype II for hepatitis C virus genotyping. Clinical Chemistry and Laboratory Medicine 48:4.
Crossref
Andreas Erhardt, Katja Deterding, Yves Benhamou, Markus Reiser, Xavier Forns, Stanislas Pol, José Luis Calleja, Susanne Ross, Hans Christian Spangenberg, Javier Garcia-Samaniego, Michael Fuchs, Jaime Enríquez, Johannes Wiegand, Jerry Stern, Kate Wu, George Kukolj, Martin Marquis, Pierre Beaulieu, Gerhard Nehmiz & Jürgen Steffgen. (2009) Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment. Antiviral Therapy 14:1, pages 23-32.
Crossref
Jannick Verbeeck, Mark J. Stanley, Jen Shieh, Linda Celis, Els Huyck, Elke Wollants, Judy Morimoto, Alice Farrior, Erwin Sablon, Margaret Jankowski-Hennig, Carl Schaper, Pamela Johnson, Marc Van Ranst & Marianne Van Brussel. (2008) Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0. Journal of Clinical Microbiology 46:6, pages 1901-1906.
Crossref
Olav Dalgard. (2005) Follow‐Up Studies of Treatment for Hepatitis C Virus Infection among Injection Drug Users. Clinical Infectious Diseases 40:s5, pages S336-S338.
Crossref
Fabio Tinè, Massimo Attanasio, Francesca Russo & Luigi Pagliaro. (2005) A decade of trials of interferon-alpha for chronic hepatitis C. A meta-regression analysis. Contemporary Clinical Trials 26:2, pages 179-210.
Crossref
B. J. Veldt, B. E. Hansen, M. J. C. Eijkemans, R. J. Knegt, T. Stijnen, J. D. F. Habbema & S. W. Schalm. (2005) Dynamic decision analysis to determine optimal treatment duration in chronic hepatitis C. Alimentary Pharmacology and Therapeutics 21:5, pages 539-547.
Crossref
S. S. Lee. (2003) Indicators and predictors of response to anti-viral therapy in chronic hepatitis C. Alimentary Pharmacology & Therapeutics 17:5, pages 611-621.
Crossref
Raj Barathur, Jack Bookout, Srinand Sreevatsan, John Gordon, Martina Werner, Gautam Thor & Mark Worthington. (2002) New disc-based technologies for diagnostic and research applications. Psychiatric Genetics 12:4, pages 193-206.
Crossref
Joanna S. Ellis & Maria C. Zambon. (2002) Molecular diagnosis of influenza. Reviews in Medical Virology 12:6, pages 375-389.
Crossref
M.P.H Stumpf & O.G Pybus. (2002) Genetic diversity and models of viral evolution for the hepatitis C virus. FEMS Microbiology Letters 214:2, pages 143-152.
Crossref
Chi Kong Li, Paul K. S. Chan, Siu Cheung Ling & Shau Yin Ha. (2002) Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major. British Journal of Haematology 117:3, pages 755-758.
Crossref
S Distante, K Bjøro, KB Hellum, B Myrvang, JP Berg, K Skaug, N Raknerud & H Bell. (2002) Raised serum ferritin predicts non‐response to interferon and ribavirin treatment in patients with chronic hepatitis C infection. Liver 22:3, pages 269-275.
Crossref
Yupeng He & Michael G. Katze. (2002) To Interfere and to Anti-interfere: The Interplay Between Hepatitis C Virus and Interferon. Viral Immunology 15:1, pages 95-119.
Crossref
Vincent G. Bain. (2001) Effect of HCV viral dynamics on treatment design: lessons learned from HIV. The American Journal of Gastroenterology 96:10, pages 2818-2828.
Crossref
J. L. Kinzie, P. H. Naylor, M. G. Nathani, R. R. Peleman, M. N. Ehrinpreis, M. Lybik, J. R. Turner, J. J. Janisse, M. Massanari & M. G. Mutchnick. (2001) African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians. Journal of Viral Hepatitis 8:4, pages 264-269.
Crossref
Gerd Hempel, Peter R. Galle & Hanns F. Löhr. (2001) Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon‐α‐treated patients with chronic hepatitis C. Journal of Medical Virology 64:3, pages 340-349.
Crossref
Xiaofeng Fan & Adrian M. Di Bisceglie. (2001) Genetic characterization of hypervariable region 1 in patients chronically infected with hepatitis C virus genotype 2. Journal of Medical Virology 64:3, pages 325-333.
Crossref
S. J Read. (2000) Molecular techniques for clinical diagnostic virology. Journal of Clinical Pathology 53:7, pages 502-506.
Crossref
Trepo. (2000) Genotype and viral load as prognostic indicators in the treatment of hepatitis C. Journal of Viral Hepatitis 7:4, pages 250-257.
Crossref
Kondili, Taliani, Tosti, De Bac, Pasquazzi & Mele. (2000) Methodological issues in papers on IFN therapy: time for reappraisal. Journal of Viral Hepatitis 7:3, pages 184-195.
Crossref
George Webster, Eleanor Barnes, David Brown & Geoffrey Dusheiko. (2000) HCV genotypes—role in pathogenesis of disease and response to therapy. Best Practice & Research Clinical Gastroenterology 14:2, pages 229-240.
Crossref
Peter Simmonds. 2000. Hepatitis C. Hepatitis C 53 70 .
M.L.A. Oliveira, F.I. Bastos, R.R. Sabino, U. Paetzold, E. Schreier, G. Pauli & C.F.T. Yoshida. (1999) Distribution of HCV genotypes among different exposure categories in Brazil. Brazilian Journal of Medical and Biological Research 32:3, pages 279-282.
Crossref
Lena Daghestani & Claire Pomeroy. (1999) Renal manifestations of hepatitis C infection. The American Journal of Medicine 106:3, pages 347-354.
Crossref
A. Wenke, S. Schmidt, I. Stier-Brück, H. Stoll, N. Werner, B. Zwinge, S. Zeuzem & I. Scharrer. 1999. 28. Hämophilie-Symposion Hamburg 1997. 28. Hämophilie-Symposion Hamburg 1997 290 302 .
E.S. Berg, L.M. Jarvis, P. Simmonds, H. Bell & K. Skaug. (1998) Detection of GB virus C RNA by GBV-C LCx and two PCR assays with primers from the 5′ non-coding and NS5B region. Journal of Virological Methods 76:1-2, pages 43-49.
Crossref
Srinand SreevatsanJack B. BookoutFidel M. RingpisMridula R. PottathilDavid J. Marshall, Monika De Arruda, Christopher Murvine, Lance Fors, Raveendran M. Pottathil & Raj R. Barathur. (1998) Algorithmic Approach to High-Throughput Molecular Screening for Alpha Interferon-Resistant Genotypes in Hepatitis C Patients. Journal of Clinical Microbiology 36:7, pages 1895-1901.
Crossref
C. A. Lee, C. M. Kessler, D. Varon, U. Martinowitz, M. Heim & G. M. DUSHEIKO. (2003) Therapy for chronic hepatitis B and C infection in haemophilia. Haemophilia 4:4, pages 577-586.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.